Inspire Investing’s CareDx CDNA Stock Holding History

Inspire Investing’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,336	Closed	-$459K	–	619
2020 Q4	$459K	Buy	+6,336	New	+$367K	0.1%	201

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Inspire Investing's CDNA Position: Q1 2021 in Review

Inspire Investing sold out of CareDx (CDNA) in Q1 2021, closing a stake of 6,336 shares — an estimated $459K sold.

Inspire Investing first reported a position in CDNA in Q4 2020 and held it in 1 quarter. The position peaked at $459K in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

Inspire Investing reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
Inspire Investing sold 6,336 CareDx shares in Q1 2021, an estimated $459K.
Inspire Investing first reported a position in CareDx in Q4 2020 and held it in 1 quarter.
Inspire Investing's CareDx position peaked at $459K in Q4 2020.
245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Inspire Investing's 13F filing for Q1 2021, filed 30 Apr 2021.